191 related articles for article (PubMed ID: 6410639)
41. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone.
Duntas L; Roussel JP; Astier H; Keck FS; Rosenthal J; Pfeiffer EF
Pharmacology; 1991; 43(2):106-12. PubMed ID: 1775509
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of prolactin secretion by oestradiol in the rat is associated with increased hypothalamic release of thyrotrophin-releasing hormone.
Franks S; Mason HD; Shennan KI; Sheppard MC
J Endocrinol; 1984 Nov; 103(2):257-61. PubMed ID: 6436427
[TBL] [Abstract][Full Text] [Related]
43. Effect of endogenous opioid peptides on TRH release from rat stomach in vitro.
Mitsuma T; Hirooka Y; Nakada K; Nomura A; Nogimori T
Endocrinol Exp; 1989 Mar; 23(1):11-6. PubMed ID: 2565806
[TBL] [Abstract][Full Text] [Related]
44. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
Spitz IM; Sheinfeld M; Glasser B; Hirsch HJ
Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
[TBL] [Abstract][Full Text] [Related]
45. Effect of thyrotrophin releasing hormone (TRH) in patients with pituitary disorders.
Lindholm J; Dige-Petersen H; Hummer L; Rasmussen P; Korsgaard O
Acta Endocrinol (Copenh); 1977 Jul; 85(3):479-87. PubMed ID: 405835
[TBL] [Abstract][Full Text] [Related]
46. Normal response to thyrotrophin releasing hormone (TRH) in familial thyroxine-binding globulin deficiency.
Hansen E; Kirkegaard C; Friis T; Siersbaek-Nielsen K
Acta Endocrinol (Copenh); 1975 Oct; 80(2):279-301. PubMed ID: 52266
[TBL] [Abstract][Full Text] [Related]
47. Role of postnatal gonadal function in the determination of thyrotropin (TSH) releasing hormone-induced TSH response in adult male and female rats.
Watanobe H; Takebe K
Endocrinology; 1987 May; 120(5):1711-8. PubMed ID: 3032567
[TBL] [Abstract][Full Text] [Related]
48. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
Haug E; Frey HM; Sand T
Acta Endocrinol (Copenh); 1977 Jun; 85(2):335-44. PubMed ID: 405834
[TBL] [Abstract][Full Text] [Related]
49. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis.
van Haasteren GA; van der Meer MJ; Hermus AR; Linkels E; Klootwijk W; Kaptein E; van Toor H; Sweep CG; Visser TJ; de Greef WJ
Endocrinology; 1994 Oct; 135(4):1336-45. PubMed ID: 7925094
[TBL] [Abstract][Full Text] [Related]
50. Hypothalamic secretion of thyrotropin releasing hormone declines in aging rats.
Pekary AE; Mirell CJ; Turner LF; Walfish PG; Hershman JM
J Gerontol; 1987 Jul; 42(4):447-50. PubMed ID: 3110255
[TBL] [Abstract][Full Text] [Related]
51. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
Frey HM; Haug E
Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
[TBL] [Abstract][Full Text] [Related]
52. Effects of calcium hopantenate on the hypothalamic-pituitary-thyroid axis in rats.
Mitsuma T; Nogimori T
Horm Res; 1983; 18(4):210-4. PubMed ID: 6416983
[TBL] [Abstract][Full Text] [Related]
53. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
Andreassen B; Huth J; Tyson JE
Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
[TBL] [Abstract][Full Text] [Related]
54. Bromocriptine suppresses the thyrotrophin response to thyrotrophin releasing hormone during human pregnancy.
Ylikorkala O; Kivinen S; Rönnberg L; Viinikka L
Clin Endocrinol (Oxf); 1980 Sep; 13(3):253-7. PubMed ID: 6783349
[TBL] [Abstract][Full Text] [Related]
55. Age-related decreases in the thyrotropin (TSH) responsiveness to thyrotropin-releasing-hormone (TRH) stimulation and to the inhibitory effect of triiodothyronine (T3); in vitro study on superfused rat pituitaries.
Szabolcs I; Schultheiss H; Astier H; Horster FA
Exp Gerontol; 1991; 26(4):347-55. PubMed ID: 1936193
[TBL] [Abstract][Full Text] [Related]
56. Normal thyrotrophin response to intravenous thyrotrophin releasing hormone administration: the best index of optimal L-thyroxine therapy in primary hypothyroidism.
Kabadi UM
Postgrad Med J; 1985 Aug; 61(718):685-8. PubMed ID: 3929241
[TBL] [Abstract][Full Text] [Related]
57. Hypothalamic secretion of thyrotrophin releasing hormone is decreased in male Japanese quail exposed to long daily photoperiods.
Almeida OF
J Endocrinol; 1982 Feb; 92(2):261-5. PubMed ID: 6801171
[TBL] [Abstract][Full Text] [Related]
58. Thyrotropin expression in hypophyseal pars tuberalis-specific cells is 3,5,3'-triiodothyronine, thyrotropin-releasing hormone, and pit-1 independent.
Bockmann J; Böckers TM; Winter C; Wittkowski W; Winterhoff H; Deufel T; Kreutz MR
Endocrinology; 1997 Mar; 138(3):1019-28. PubMed ID: 9048604
[TBL] [Abstract][Full Text] [Related]
59. Modulation of thyrotrophin release from an intracellular pool by pre-exposure to thyrotrophin-releasing hormone and dibutyryl cyclic AMP.
Davis JR; Sheppard MC
J Endocrinol; 1986 Feb; 108(2):211-7. PubMed ID: 3005459
[TBL] [Abstract][Full Text] [Related]
60. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
Vagenakis AG; Rapoport B; Azizi F; Portnay GI; Braverman LE; Ingbar SH
J Clin Invest; 1974 Oct; 54(4):913-8. PubMed ID: 4214837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]